Mucolytic expectorant to clear and maintain airways for Horses and Dogs
COMPOSITION
Contains: Ambroxol hydrochloride 6 mg/mL
ACTIONS
AMBROXOL is a mucolytic expectorant. Ambroxol is an active metabolite of bromhexine, and acts to reduce the viscosity of tenacious mucus secretions by fragmentation of long mucopolysaccharide chains, resulting in a productive cough which aids expectoration of liquefied mucoid respiratory secretions, and assists in clearing and maintaining patent bronchioles and alveoli, hence reducing dyspnoea.
AMBROXOL enhances the concentrations of chemotherapeutic agents in bronchial secretions to result in a more rapid recovery.
INDICATIONS
AMBROXOL is indicated to aid in the treatment of catarrhal inflammation of bronchi and the upper respiratory tract in horses and dogs.
Specific indications include:
Chest Infections: acute and chronic bronchopneumonia, catarrhal rhinitis, strangles, post-viral cough
Uterine Infections: pyometron, mucometron
Ocular Infections: purulent conjunctivitis, hypopion
DOSAGE AND ADMINISTRATION
Horses:
0.3 mg/kg (5 mL/100 kg) bodyweight by intravenous injection twice daily.
Dogs:
0.6 mg/kg (1 mL/10 kg) bodyweight by intravenous injection twice daily.
<
Administer AMBROXOL by intravenous injection.
It is safe to use AMBROXOL for extended periods.
PRESENTATION
100 mL sterile multi-dose glass vial.
STORAGE
Store below 25°C (Air Conditioning). Protect from light.
WARNINGS
Meat Withholding Period [Horses]: 28 Days
If used in performance animals, the regulations of the relevant authorities regarding medication should be observed.
COMPOSITION
Contains: Ambroxol hydrochloride 6 mg/mL
ACTIONS
AMBROXOL is a mucolytic expectorant. Ambroxol is an active metabolite of bromhexine, and acts to reduce the viscosity of tenacious mucus secretions by fragmentation of long mucopolysaccharide chains, resulting in a productive cough which aids expectoration of liquefied mucoid respiratory secretions, and assists in clearing and maintaining patent bronchioles and alveoli, hence reducing dyspnoea.
AMBROXOL enhances the concentrations of chemotherapeutic agents in bronchial secretions to result in a more rapid recovery.
INDICATIONS
AMBROXOL is indicated to aid in the treatment of catarrhal inflammation of bronchi and the upper respiratory tract in horses and dogs.
Specific indications include:
Chest Infections: acute and chronic bronchopneumonia, catarrhal rhinitis, strangles, post-viral cough
Uterine Infections: pyometron, mucometron
Ocular Infections: purulent conjunctivitis, hypopion
DOSAGE AND ADMINISTRATION
Horses:
0.3 mg/kg (5 mL/100 kg) bodyweight by intravenous injection twice daily.
Dogs:
0.6 mg/kg (1 mL/10 kg) bodyweight by intravenous injection twice daily.
<
Administer AMBROXOL by intravenous injection.
It is safe to use AMBROXOL for extended periods.
PRESENTATION
100 mL sterile multi-dose glass vial.
STORAGE
Store below 25°C (Air Conditioning). Protect from light.
WARNINGS
Meat Withholding Period [Horses]: 28 Days
If used in performance animals, the regulations of the relevant authorities regarding medication should be observed.
- [Zebravet_Files]:
- [Zebravet_Files]
- Classification:
- S4
- Categorisation:
- Prescription
Are you a Vet?
This section contains restricted pharmaceutical products. Are you a registered veterinarian?